Our mission has always been to improve the quality of life for patients; indeed, we have sold over 90,000 of our ASD devices outside of the U.S. Now, with the FDA's approval, ...

The Occlutech ASD Occluder is associated with "positive procedural outcomes, low rate of complications ... SCHAFFHAUSEN, CH / ACCESSWIRE / August 28, ...

August 5, 2011 (Silver Spring, Maryland) — The US FDA has provided heartwire with figures from its MAUDE database on erosions with Amplatzer septal-occluder devices (St Jude Medical) until July ...

The ASD devices are still available, ... Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004 [research letter]. JAMA 2008; 299:521-522 ...

Maria was born with a birth defect called Atrial Septal Defect (ASD), having a hole in the wall (septum) between the two upper chambers of heart. As a result, some oxygenated blood from the left ...

SCHAFFHAUSEN, Switzerland, January 12, 2016 /PRNewswire/ -- Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained Japanese MHW approval ...

Our mission has always been to improve the quality of life for patients; indeed, we have sold over 90,000 of our ASD devices outside of the U.S. Now, with the FDA's approval, we are poised to leverage ...

Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained Japanese MHW approval for its dedicated Atrial Septal Defect Closure Device. The ...